Heart replacement: artificial heart 7 PDF
Preview Heart replacement: artificial heart 7
Cover Page i Heart Replacement Artificial Heart 7 Tetsuzo Akutsu Hitoshi Koyanagi Page ii This page intentionally left blank. Page iii Heart Replacement Artificial Heart 7 The 7th International Symposium on Artificial Hearts and Assist Devices 2000 Tokyo, Japan Published by Isis Medical Media Limited in collaboration with Nankodo Company Limited EDITORS: Tetuzo Akutsu MD, PhD Chariman, Terumo Corporation, Shonan Center, 1500 Inokuchi, Nakaimachi, Ashigarakamigun, Kanagawa 259–01, Japan Hitoshi Koyanagi MD Chairman and Professor, Department of Cardiovascular Surgery The Heart Institute of Japan, Tokyo Women’s Medical College, 8–1 Kawadacho, Shinjukuku, Tokyo 162, Japan This edition published in the Taylor & Francis eLibrary, 2005. To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk. This publication was subsidized by the Japan Keirin Association through its promotion funds from KEIRIN RACE ISBN 0203994582 Master ebook ISBN ISBN 1 901865 36 3 (Print Edition) Isis Medical Media Limited © Isis Medical Media Limited, 2001 Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Isis Medical Media Limited for libraries and other users registered with the Copyright Clearance Center (CCC) Transactional Reporting Service, provided that the base fee of $15.00 per copy is paid directly to CCC, 27 Congress Street, Salem, MA 0–1970, USA. 0306–5456/92 $15.00. Product liability: The publisher gives no guarantee for information about drug dosage and application thereof contained in this publication. In every individual case the respective user must check its accuracy by consulting other pharmaceutical literature. Page iv Heart Replacement Artificial Heart 7 Heart Replacement, Artificial Heart 7, is published in conjunction with the Journal of Congestive Heart Failure & Circulatory Support. The journal is published quarterly and the subscription rates, including postage, for 2001 are: Institutional subscription £180.00/$280.00 Individual subscription £90.00/$150.00 Subscribers in Canada must add 7% to the value of their order to allow for Canadian GST. Subscribers in Europe must quote their VAT registration number or state that they are not registered. Subscribers in the Netherlands who are not VAT registered must add 6% to the subscription price, to allow for VAT. Orders for subscriptions, back issues and business correspondence should be sent to: Subscription Manager Martin Dunitz Limited The Livery House 7–9 Pratt Street London, NW1 0AE Tel: +44 (0)20 7482 2202, Fax: +44 (0)207 267 0159 Dispatch The journal is dispatched within Europe by surface mail, to other continents by various forms of airspeeded delivery: to the US by air freight for forwarding by second class post, to India by air freight for guaranteed local delivery, and to all other countries by accelerated surface post. Copyright and photocopying All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the prior written permission of the author and editor, and the customary acknowledgements must be made. © 2001 Isis Medical Media Limited. Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Isis Medical Media Limited for libraries and other users registered with the Copyright Clearance Center (CCC) Transactional Reporting Service, provided that the base fee of $15.00 per copy is paid directly to CCC, 27 Congress Street, Salem, MA 01970, USA. 0306–5456/92 $15.00. This consent does not extend to the kinds of copying, such as copying for general distribution, for advertising or promotional purposes, for creating new collective works, or for resale. Special requests should be sent to the Editor. ISSN 1365–5736 Isis Medical Media Staff Journals’ Editor: Harriet Milles Production Controller: Sarah Sodhi Typesetting, artwork and image reproduction by J&L Composition Ltd., Filey, UK Printed in Hong Kong This journal is printed on acidfree paper. Page v Heart Replacement Artificial Heart 7 The 7th International Symposium on Artificial Heart and Assist Devices Tokyo, Japan March 10–11, 2000 Organizing Committee Honorary President Hiromitsu Yoshioka Chairman, Board of Directors Tokyo Women’s Medical University President Kintomo Takakura President, Tokyo Women’s Medical University Vice President Tetsuzo Akutsu Senior Advisor, Terumo Corporation Secretary General Hitoshi Koyanagi Professor and Chairman Department of Cardiovascular Surgery The Heart Institute of Japan Tokyo Women’s Medical University Members Tetsuzo Akutsu Senior Advisor, Terumo Corporation OH Frazier Chief of Transplant Services, Texas Heart Institute Kou Imachi Professor, The University of Tokyo Kazunori Kataoka Professor, The University of Tokyo Akahiko Kawai Assistant Professor, Tokyo Women’s Medical University Robert L Kormos Associate Professor, University of Pittsburgh Hitoshi Koyanagi Professor, Tokyo Women’s Medical University Hikaru Matsuda Professor, Osaka University Hiroshi Nishida Assistant Professor, Tokyo Women’s Medical University Shinichi Nitta Professor, Tohoku University Chisato Nojiri Research Manger, Terumo Corporation Yoshiyuki Taenaka Director, National Cardiovascular Center Research Institute Setsuo Takatani Professor, Tokyo Medical and Dental University Ryohei Yozu Assistant Professor, Keio University John T Watson Active Deputy Director, Lung and Vascular Diseases, NHLBI Page vi This page intentionally left blank. Page vii Preface It is a great pleasure for me to offer you here the Proceedings of the 7th International Symposium on Artificial Heart and Assist Devices which was held at Keidanren Kaikan in Tokyo, Japan, March 10–11, 2000. Although some reports of clinical uses of total artificial heart (TAH) and ventricular assist devices (VAD) were presented in the 6th Symposium, the number of presentations has apparently increased in this Symposium. The bridge use of TAH and/or VAD has also increased. In Japan, however, only one bridge use was reported due to the slow acceptance of brain death heart transplantation. The Proceeding sconsit of ten sessions and 6 invited lectures: they are TAH (2), VAD (4), HT, engineering (2), pathophysiology and biomaterial. The development of hardware in the field of artificial hearts is making excellent progress toward small, implantable, and durable devices. I hope the Proceedings will be a beneficial asset to both experts and young investigators. Tetsuzo Akutsu VicePresident Past and future perspective of the Symposium Sixteen years have passed since the 1st Symposium on Artificial Heart and Assist Devices was held in 1985. Since then, the Symposium has been held in Tokyo, usually biennially, in the midsummers of 1985, 1987, 1990, 1992, 1995, 1996 and 2000. Everyone who has attended the Symposia will remember the weather in downtown Tokyo, which could be described as ‘somewhat tropical’! Dedicated and enthusiastic investigators from the world’s major artificial heart laboratories and Institutions, conducting active heart transplantation programs, were invited to all seven Symposia. By 1985, Japan had finally recovered from difficulties experienced after the Second World War and has since made remarkable advances in all scientific fields, including cardiovascular surgery and cardiology. However, the effective treatment of intractable severe heart failure seemed to be lagging behind compared to other counties. Therefore, under the direction of Dr. Akutsu, I instigated the 1 st Symposium, hoping that it would be an informative, stimulating and encouraging forum. The Symposium has now been an established event for sixteen years, and has involved seven Symposia and six issues of Proceedings. We here present the publication of the 7th Proceedings. Over recent years, striking changes have occurred in our environment, not only in Japan but also throughout the world. The concepts presented at the Symposia have led to significant advances in medical technology. In the new millennium we hope to benefit still further from the continued development of excellent devices for the treatment of severe heart failure. I propose that the Symposium should be continued for this purpose. Thank you again for your wonderful support. I am looking forward to seeing all of you here in Tokyo in the new millennium. Hitoshi Koyanagi, MD Secretary General © 2001 Isis Medical Media Limited Page viii This page intentionally left blank. Page ix Congratulatory Addresses Good morning, honorable participants, distinguished guests, ladies and gentlemen. My name is Kazunari Asanuma, Deputy Director of the Research and Development Division at the Ministry of Health and Welfare. I apologise that Dr Ito is unable to attend the Symposium, and I am here to read the following statement on his behalf. It is my great pleasure to be present for this opening ceremony of the 7th International Symposium on Artificial Heart and Assist Devices. With the rapid progress in science and technology, many medical devices have been developed which have proved enormously beneficial to the advancement of medical procedures. In the 21st century, with an aging population and fewer children, the development of new, effective medical devices becomes increasingly important to improve quality of life. The shortage of heart donors in our country means that Japanese patients with severe heart disease generally have to wait for long periods for heart transplantation Therefore, the Ministry of Health and Welfare actively promotes research and development in artificial hearts and assist devices by use of health science research funding. I believe that many researchers will continue their contribution to the development of new, effective medical devices as a bridge to heart transplantation. With this goal in view, I am convinced that the Symposium will be a successful forum for research into the future development of artificial hearts and assist devices. I hope that this 7th Symposium will prove to be a fruitful event for all of you. Finally, I extend my sincere thanks to Mr Yoshioka, Dr Takakura, Dr Akutsu and Professor Koyanagi for the organization of this Symposium. Thank you for listening. Kazunari Asanuma Deputy Director, Research and Development Division, Ministry of Health and Welfare, Japan Ladies and gentlemen I would like, first of all, to congratulate the Japan Research Promotion Society for Cardiovascular Diseases and all those who have made efforts to convene for this 7th International Symposium on Artificial Heart and Assist Devices. It is a great honor for me to have an opportunity to speak at this important Symposium. As the Director of the Life Science Division of the Science and Technology Agency, I am in charge of the promotion of life science. Life science aims first at elucidating the complex and sophisticated phenomenon of life and then utilizing its result for health medicine, environmental protection, agriculture, forestry and fisheries, and industry, with the aim of achieving a healthy and productive national lifestyle. In the budget for this year, a millennium project was advocated by our Prime Minister. Life science is generally held to be the most important aspect of science and technology because it promotes bioindustry, which is a key to the rebirth of our economy, and a happy society that enjoys longevity Life science includes research on artificial organs, and to finding solutions to various problems in human health. The research into artificial organs, which we are about to discuss today, is, in my view, of great importance in Japan, where the number of elderly people is rapidly increasing. It goes without saying that research on artificial organs requires extensive cooperation and coordination among research institutions and researchers in such fields as medicine, biology, and engineering. I believe that this Symposium will provide participants with an extremely useful opportunity to exchange the most upto date research information, which, I am sure, will greatly contribute to significant progress in this field. Thank you very much for your attention. Kimihiko Oda Director of Life Science Division, Science Technology Agency, Japan © 2001 Isis Medical Media Limited
The list of books you might like
